These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9029405

  • 1. Rat strain differences in the vulnerability of serotonergic nerve endings to neurotoxic damage by p-chloroamphetamine.
    Zhou D, Schreinert M, Pilz J, Huether G.
    J Neural Transm (Vienna); 1996; 103(12):1381-95. PubMed ID: 9029405
    [Abstract] [Full Text] [Related]

  • 2. Long-term modulation of presynaptic 5-HT-output: experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density.
    Huether G, Zhou D, Rüther E.
    J Neural Transm (Vienna); 1997; 104(10):993-1004. PubMed ID: 9503252
    [Abstract] [Full Text] [Related]

  • 3. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
    Gobbi M, Moia M, Pirona L, Ceglia I, Reyes-Parada M, Scorza C, Mennini T.
    J Neurochem; 2002 Sep; 82(6):1435-43. PubMed ID: 12354291
    [Abstract] [Full Text] [Related]

  • 4. Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus.
    Hensler JG, Ferry RC, Labow DM, Kovachich GB, Frazer A.
    Synapse; 1994 May; 17(1):1-15. PubMed ID: 8042142
    [Abstract] [Full Text] [Related]

  • 5. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
    Rothman RB, Jayanthi S, Wang X, Dersch CM, Cadet JL, Prisinzano T, Rice KC, Baumann MH.
    Synapse; 2003 Dec 01; 50(3):233-9. PubMed ID: 14515341
    [Abstract] [Full Text] [Related]

  • 6. Rat brain serotonin neurones that express neuronal nitric oxide synthase have increased sensitivity to the substituted amphetamine serotonin toxins 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
    De Silva DJ, French SJ, Cheung NY, Swinson AK, Bendotti C, Rattray M.
    Neuroscience; 2005 Dec 01; 134(4):1363-75. PubMed ID: 16054768
    [Abstract] [Full Text] [Related]

  • 7. Serotonergic hyperinnervation of the frontal cortex in an animal model of depression, the bulbectomized rat.
    Zhou D, Grecksch G, Becker A, Frank C, Pilz J, Huether G.
    J Neurosci Res; 1998 Oct 01; 54(1):109-16. PubMed ID: 9778154
    [Abstract] [Full Text] [Related]

  • 8. Differential sensitivities to the lethal, but not the neurotoxic, effects of p-chloroamphetamine in inbred rat strains.
    Fernandez F, Aguerre S, Mormède P, Chaouloff F.
    Neurosci Lett; 2001 Jan 05; 297(1):53-7. PubMed ID: 11114483
    [Abstract] [Full Text] [Related]

  • 9. Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity.
    Brown P, Molliver ME.
    J Neurosci; 2000 Mar 01; 20(5):1952-63. PubMed ID: 10684896
    [Abstract] [Full Text] [Related]

  • 10. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
    Xie T, Tong L, McLane MW, Hatzidimitriou G, Yuan J, McCann U, Ricaurte G.
    Neuropsychopharmacology; 2006 Dec 01; 31(12):2639-51. PubMed ID: 16452989
    [Abstract] [Full Text] [Related]

  • 11. Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice.
    Itzhak Y, Achat-Mendes CN, Ali SF, Anderson KL.
    Neuropharmacology; 2004 Jan 01; 46(1):74-84. PubMed ID: 14654099
    [Abstract] [Full Text] [Related]

  • 12. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
    Owens MJ, Ballenger CA, Knight DL, Nemeroff CB.
    J Pharmacol Exp Ther; 1996 Sep 01; 278(3):1040-9. PubMed ID: 8819484
    [Abstract] [Full Text] [Related]

  • 13. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
    Dewar KM, Grondin L, Carli M, Lima L, Reader TA.
    J Neurochem; 1992 Jan 01; 58(1):250-7. PubMed ID: 1370077
    [Abstract] [Full Text] [Related]

  • 14. Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives.
    Mamounas LA, Mullen CA, O'Hearn E, Molliver ME.
    J Comp Neurol; 1991 Dec 15; 314(3):558-86. PubMed ID: 1814975
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of three transporter ligands as quantitative markers of serotonin innervation density in rat brain.
    Descarries L, Soucy JP, Lafaille F, Mrini A, Tanguay R.
    Synapse; 1995 Oct 15; 21(2):131-9. PubMed ID: 8584974
    [Abstract] [Full Text] [Related]

  • 17. Acute regulation and long-term modulation of presynaptic serotonin output.
    Huether G.
    Adv Exp Med Biol; 1999 Oct 15; 467():1-10. PubMed ID: 10721032
    [Abstract] [Full Text] [Related]

  • 18. p-Chlorphenylalanine changes serotonin transporter mRNA levels and expression of the gene product.
    Rattray M, Baldessari S, Gobbi M, Mennini T, Samanin R, Bendotti C.
    J Neurochem; 1996 Aug 15; 67(2):463-72. PubMed ID: 8764569
    [Abstract] [Full Text] [Related]

  • 19. Effects of dexfenfluramine or 5,7-dihydroxytryptamine on tryptophan hydroxylase and serotonin transporter mRNAS in rat dorsal raphe.
    Semple-Rowland SL, Mahatme A, Rowland NE.
    Brain Res Mol Brain Res; 1996 Sep 05; 41(1-2):121-7. PubMed ID: 8883942
    [Abstract] [Full Text] [Related]

  • 20. Ipsilateral alterations in tryptophan hydroxylase activity in rat brain after hypothalamic 5,7-di-hydroxytryptamine lesion.
    Ljubić-Thibal V, Diksic M, Hamel E, Raison S, Pujol JF, Weissmann D.
    Brain Res; 1996 Jun 17; 724(2):222-31. PubMed ID: 8828572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.